See also this year's filing and all EDGAR filings for this company.
PDF Report 0001437786_2015_Immune_Design_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Immune Pharmaceuticals INC', 'shared_tokens': {'immune'}}]} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001437786, Immune Design CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 77,982,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 401,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 11,947,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,927,000 |
| 9 | ResearchAndDevelopmentExpense | 22,746,000 |
| 10 | remainder_Expenses | 638,000 |
| 11 | remainder_Revenues | 6,433,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 78,383,000 |
| 1 | Liabilities | 11,947,000 |
| 2 | Expenses | 36,311,000 |
| 3 | Revenues | 6,433,000 |
| 4 | StockholdersEquity | 66,436,000 |
| 5 | NetIncome | -29,878,000 |
| 6 | ComprehensiveNetIncome | -29,878,000 |
| 7 | BaseVar | 66,537,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.55 |
| 9 | EconomicCapitalRatio | 3.39 |
Edgar->Model Mapping
Feature Distribution
